Literature DB >> 11821819

A time trend of profile and surgical results in 1123 patients with non-small cell lung cancer.

Ichiro Yoshino1, Hiromitsu Baba, Seiichi Fukuyama, Toshifumi Kameyama, Yasunori Shikada, Makiko Tomiyasu, Ryuichi Suemitsu.   

Abstract

BACKGROUND: A time trend for characteristics and prognoses of patients with non-small cell lung cancer (NSCLC) who underwent surgical resection was investigated.
METHODS: A series of 1123 consecutive patients with NSCLC who underwent surgical resection from 1975 to 1998 was reviewed with respect to changes in patient profile and surgical outcome among subgroups classified by clinicopathologic factors.
RESULTS: With time, the proportion of female, elderly (> or =70 years), pathologic stage IA, nonsmoking, and adenocarcinoma patients increased significantly whereas pneumonectomy, incomplete resection, and pathologic stage IIIA patients decreased significantly. Overall survival showed an upward trend with 5-year survival rates of 30.0% in the 1970s, 41.6% in the 1980s, and 50.1% in the 1990s (P <.0001). This tendency was similar in every pathologic stage that was observed. The proportion of female patients with adenocarcinoma that exhibited the most favorable prognosis among subpopulations classified by gender and cell types was significantly higher in the 1990s (28.0%) than in the 1970s (14.0%). Multivariate analysis revealed that female gender, adenocarcinoma, complete resection, and early pathologic stage were independently favorable factors whereas advanced age was an unfavorable factor.
CONCLUSIONS: The improved survival following surgical resection for NSCLC during the study period was associated with an increasing population of female patients with adenocarcinoma, more detection of early disease, and effective elimination of unresectable cases.

Entities:  

Mesh:

Year:  2002        PMID: 11821819     DOI: 10.1067/msy.2002.119796

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

1.  When in doubt should we cut it out? The role of surgery in non-small cell lung cancer.

Authors:  J-E C Holty; M K Gould
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

Review 2.  Impact of smoking status on the biological behavior of lung cancer.

Authors:  Ichiro Yoshino; Yoshihiko Maehara
Journal:  Surg Today       Date:  2007-08-27       Impact factor: 2.549

3.  Surgical outcome of an anatomical resection of clinical stage IA non-small cell lung cancer assisted with a video-thoracoscopy.

Authors:  Ichiro Yoshino; Masafumi Yamaguchi; Koji Yamazaki; Fumihiro Shoji; Motoharu Hamatake; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

4.  Third-line therapy for advanced non-small-cell lung cancer patients: feasible drugs for feasible patients.

Authors:  Zhengbo Song; Yongfeng Yu; Zhiwei Chen; Shun Lu
Journal:  Med Oncol       Date:  2010-11-30       Impact factor: 3.064

5.  Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer.

Authors:  Dan Li; Xianglin L Du; Yinghong Ren; Peijun Liu; Shuting Li; Jiao Yang; Meng Lv; Ling Chen; Xin Wang; Enxiao Li; Jin Yang; Min Yi
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

6.  [Multivariate survival analysis of patients with stage I NSCLC].

Authors:  Jun Pei; Baohui Han; Jie Zhang; Aiqin Gu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-12

7.  Changes in the demographics and prognoses of patients with resected non-small cell lung cancer: a 20-year experience at a single institution in Korea.

Authors:  Jin Gu Lee; Chang Young Lee; Mi Kyung Bae; Chun Sung Byun; Dae Joon Kim; Kyung Young Chung
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.